AIM ImmunoTech Inc (AIM)

AIM ImmunoTech (AIM) Income Statement


AIM ImmunoTech Income Statement

Last quarter (Q4 2022), AIM ImmunoTech's total revenue was $49.00K, an increase of 48.48% from the same quarter last year. In Q4, AIM ImmunoTech's net income was $5.03M. See AIM ImmunoTech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 157.00K$ 141.00K$ 135.00K$ 163.00K$ 140.00K$ 367.00K
Cost of Revenue
$ -77.00K-$ 850.00K$ 806.00K$ 893.00K$ 884.00K
Gross Profit
$ 234.00K$ 141.00K$ -715.00K$ -643.00K$ -753.00K$ -517.00K
Operating Expense
$ 12.61M$ 20.06M$ 16.34M$ 14.37M$ 11.69M$ 10.98M
Operating Income
$ -12.38M$ -19.92M$ -17.06M$ -15.02M$ -12.44M$ -11.50M
Net Non Operating Interest Income Expense
$ 127.00K-$ -67.00K$ -672.00K$ -338.00K$ -470.00K
Other Income Expense
$ -1.20M$ 1.01M$ -2.00M$ 1.29M$ 3.38M$ 2.14M
Pretax Income
$ -11.59M$ -20.93M$ -19.13M$ -14.40M$ -9.40M$ -9.83M
Tax Provision
$ -1.61M$ -1.61M----
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -10.60M$ -19.45M$ -19.13M$ -14.40M$ -9.40M$ -9.83M
Basic EPS
$ -0.40$ -0.40$ -0.40$ -0.45$ -2.62$ -9.77
Diluted EPS
$ -0.31$ -0.40$ -0.40$ -0.45$ -2.62$ -9.77
Basic Average Shares
$ 192.56M$ 48.05M$ 47.34M$ 31.84M$ 3.64M$ 1.00M
Diluted Average Shares
$ 144.51M$ 48.05M$ 47.34M$ 31.84M$ 3.64M$ 1.00M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 12.54M$ 20.06M$ 17.19M$ 15.18M$ 12.58M$ 11.86M
Net Income From Continuing And Discontinued Operation
$ -19.29M$ -19.45M$ -19.13M$ -14.40M$ -9.40M$ -9.83M
Normalized Income
$ -10.40M-$ -14.81M$ -14.50M$ -11.79M$ -11.69M
Interest Expense
--$ 67.00K$ 672.00K$ 427.00K$ 502.00K
$ -11.47M$ -20.93M$ -19.06M$ -13.73M$ -8.98M$ -9.32M
$ -11.20M$ -20.68M$ -18.29M$ -12.99M$ -8.19M$ -8.45M
Currency in USD

AIM ImmunoTech Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis